Renal Cancer - Results from #1340

C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab. August 23, 2022

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma. August 23, 2022

Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015. August 22, 2022

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas. August 22, 2022

Deep learning can predict survival directly from histology in clear cell renal cell carcinoma. August 19, 2022

Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma. August 19, 2022

The evolving role of contrast-enhanced ultrasound in urology: a review. August 18, 2022

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma. August 18, 2022

Knowledge mapping and research hotspots of immunotherapy in renal cell carcinoma: A text-mining study from 2002 to 2021. August 17, 2022

Percutaneous Microwave Ablation is Comparable to Cryoablation for the Treatment of T1a Renal Masses: Results From a Cross-Sectional Study. August 17, 2022

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma. August 16, 2022

Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma-Future or the Past? August 16, 2022

Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma. August 16, 2022

Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes. August 15, 2022

Identification of Pathologic Grading-Related Genes Associated with Kidney Renal Clear Cell Carcinoma. August 15, 2022

Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies. August 12, 2022

CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). August 12, 2022

Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial. August 11, 2022

Survival Improvement in Patients with Renal Cell Carcinoma and Disparities between Different Sexes, Races, and Socioeconomic Status: 1977-2016. August 11, 2022

A multiomics disease progression signature of low-risk ccRCC. August 10, 2022

Page 68 of 456